Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.

By Deepinder Kaur, F. Yantiri, Subramanian Rajagopalan, Jyothi Kumar, J. Mo, R. Boonplueang, Veena Viswanath, Russell E. Jacobs, Lichuan Yang, M. F. Beal and 6 more. Neuron, 2003

615 citations recorded by the source corpus.

Subfields: Hematology, Neurology, Nutrition and Dietetics

View Paper: https://www.semanticscholar.org/paper/2c117faf8781eefd25e312b1fdf12541a28ccf69

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hematology

1. M. Valko
2. K. Jomová

In Neurology

1. Michael Coleman
2. V. Borutaite
3. M. Fricker
4. A. Tolkovsky
5. Guy C. Brown
6. Michael Lawson
7. M. Valko
8. D. Vondrakova

In Nutrition and Dietetics

1. K. Jomová
2. Guy C. Brown
3. Michael Coleman
4. M. Valko
5. V. Borutaite
6. M. Fricker
7. A. Tolkovsky

Citations in the corpus

• Neuronal Cell Death. (2018, positive): “As discussed above, necroptosis of motor neurons may contribute to pathology in amyotrophic lateral sclerosis (ALS) (563).”
• Metals, oxidative stress and neurodegenerative disorders (2010, positive): “Pharmacologically chelated iron, for example the Fe-clioquinol complex, in a chelated form in which it cannot participate in oxidative events prevents degeneration of dopaminergic midbrain neurons [110].”